Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting Newswire.ca - Tue Jul 2, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs Newswire.ca - Tue Jun 11, 3:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million Newswire.ca - Mon May 27, 3:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain Newswire.ca - Tue May 21, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce significant advancements in the...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey Newswire.ca - Thu May 9, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Newswire.ca - Mon Apr 22, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Newswire.ca - Mon Apr 1, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval. Newswire.ca - Mon Mar 25, 4:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million Newswire.ca - Thu Mar 14, 7:36PM CDT

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study Newswire.ca - Tue Mar 5, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2450 (-2.00%)
INNPF : 0.1820 (-8.77%)

Barchart Exclusives

1 Reliable Dividend Stock to Buy at a Discount This July Barchart - Mon Jul 22, 6:30PM CDT
Here’s a dividend-paying gem trading at an attractive valuation, which investors can consider this July while it's still a bargain. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot